These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Where are we moving in the classification of idiopathic inflammatory myopathies? Tanboon J; Uruha A; Stenzel W; Nishino I Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis. Uruha A; Allenbach Y; Charuel JL; Musset L; Aussy A; Boyer O; Mariampillai K; Landon-Cardinal O; Rasmussen C; Bolko L; Maisonobe T; Leonard-Louis S; Suzuki S; Nishino I; Stenzel W; Benveniste O Neuropathol Appl Neurobiol; 2019 Aug; 45(5):513-522. PubMed ID: 30267437 [TBL] [Abstract][Full Text] [Related]
10. Myxovirus resistance protein A (MxA) expression in myositides: Sarcoplasmic expression is common in both dermatomyositis and lupus myositis. Xing C; Trivedi J; Bitencourt N; Burns DK; Reisch JS; Cai C Muscle Nerve; 2024 May; 69(5):548-555. PubMed ID: 38372203 [TBL] [Abstract][Full Text] [Related]
11. Dermatomyositis: Muscle Pathology According to Antibody Subtypes. Tanboon J; Inoue M; Saito Y; Tachimori H; Hayashi S; Noguchi S; Okiyama N; Fujimoto M; Nishino I Neurology; 2022 Feb; 98(7):e739-e749. PubMed ID: 34873015 [TBL] [Abstract][Full Text] [Related]
13. RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis. Suárez-Calvet X; Gallardo E; Pinal-Fernandez I; De Luna N; Lleixà C; Díaz-Manera J; Rojas-García R; Castellví I; Martínez MA; Grau JM; Selva-O'Callaghan A; Illa I Arthritis Res Ther; 2017 Jul; 19(1):174. PubMed ID: 28738907 [TBL] [Abstract][Full Text] [Related]
14. Is it really myositis? Mimics and pitfalls. Bhai SF; Dimachkie MM; de Visser M Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101764. PubMed ID: 35752578 [TBL] [Abstract][Full Text] [Related]
15. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders. Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996 [TBL] [Abstract][Full Text] [Related]
16. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379 [TBL] [Abstract][Full Text] [Related]
17. Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies. Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau JM; Miller FW; Selva-O'Callaghan A; Christopher-Stine L; Stenzel W; Mammen AL; Corse AM Clin Exp Rheumatol; 2021; 39(2):351-356. PubMed ID: 32896253 [TBL] [Abstract][Full Text] [Related]
18. Review: An update on inflammatory and autoimmune myopathies. Dalakas MC Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862 [TBL] [Abstract][Full Text] [Related]
19. Autophagy markers LC3 and p62 accumulate in immune-mediated necrotizing myopathy. Girolamo F; Lia A; Annese T; Giannini M; Amati A; D'Abbicco D; Tampoia M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Trojano M Muscle Nerve; 2019 Sep; 60(3):315-327. PubMed ID: 31172530 [TBL] [Abstract][Full Text] [Related]